Semaglutide vs Tirzepatide for PCOS: Which Works Better When Insulin Resistance Is the Problem?
PCOS is not just a weight problem, it is an insulin problem that causes a weight problem. That changes how the two GLP-1s compare. Here is the evidence for each in PCOS, what they do to cycles, hair and fertility, and how our doctors choose.
ALTRcare Medical Team
Clinical Editorial
Roughly one in five Indian women of reproductive age has PCOS, and for most of them insulin resistance sits underneath everything else: the weight that will not shift, the irregular cycles, the facial hair, the acne, the fertility trouble. Both semaglutide and tirzepatide lower insulin resistance and both cause weight loss, so both help PCOS. But they do not help it equally, and the differences matter more here than in plain obesity. This is the comparison for PCOS specifically. The general decision guide is here.
Why PCOS changes the comparison
In PCOS, high insulin drives the ovaries to make more androgens, which disrupt ovulation and cause the visible symptoms. Weight loss lowers insulin, which is why losing even 5% of body weight restores cycles in many women. Tirzepatide's second mechanism, GIP receptor activation, improves insulin sensitivity in fat and muscle directly, on top of what the weight loss does. That is a theoretical advantage in exactly the condition where insulin is the root problem, and the early data supports it: in trials of tirzepatide in obesity, fasting insulin and HOMA-IR fell more than with semaglutide at matched weight loss.
Semaglutide has the other advantage: more published evidence specifically in PCOS. Several small trials and a growing number of observational studies show semaglutide restoring regular cycles, lowering testosterone and improving ovulation in women with PCOS, including in Indian cohorts. Tirzepatide's PCOS-specific data is thinner simply because it is newer.
| Semaglutide | Tirzepatide | |
|---|---|---|
| Weight loss (obesity trials) | About 15% | About 20% |
| Insulin resistance | Improves, mostly via weight loss | Improves more, via weight loss plus GIP action |
| PCOS-specific trial data | More; small RCTs and Indian cohort studies | Less; mostly extrapolated from obesity and diabetes trials |
| Cycle regularity | Restored in a majority of women who lose 5% or more | Expected similar or better; data emerging |
| Oral contraceptive interaction | None significant | Reduces pill absorption for 4 weeks after each dose increase |
| Monthly cost in India | ₹1,300 to ₹4,200 generic | ₹13,000 to ₹26,000 |
The contraceptive issue, because it matters in PCOS
Many women with PCOS are on a combined oral contraceptive to regulate cycles and control androgens. Tirzepatide slows stomach emptying enough to reduce absorption of oral contraceptives, particularly in the four weeks after starting and after each dose increase. Lilly's guidance is to use a barrier method or switch to a non-oral contraceptive during those windows. Semaglutide does not carry this warning. If you are on the pill for contraception, not just for cycles, this is a real reason to prefer semaglutide, or to plan the switch to a non-oral method before starting tirzepatide.
Fertility: both are stopped before trying
Neither drug is used during pregnancy, and both are stopped at least two months before trying to conceive. Many women with PCOS use a GLP-1 precisely to restore ovulation and reach a fertility clinic's BMI target, then stop and try. For that use, the drug you choose is the one that gets you to the target in the window you have. Our weight loss before IVF guide covers the timeline and washout in detail.
How our doctors choose in PCOS
| Situation | Usually | Why |
|---|---|---|
| BMI 23 to 32, irregular cycles, budget matters | Semaglutide | Enough weight loss to restore cycles; most PCOS data; a fifth of the cost |
| BMI 35+, fasting insulin high, acanthosis (dark neck) | Tirzepatide if affordable | Stronger effect on insulin resistance and weight where both are severe |
| On the combined pill for contraception | Semaglutide | No interaction; tirzepatide needs backup contraception around dose changes |
| Prediabetes or HbA1c above 6.5 with PCOS | Tirzepatide if affordable, else semaglutide | Larger HbA1c and insulin effect |
| Preparing for IVF within 6 months | Whichever reaches the clinic's BMI in time | Both stopped 2 months before; speed matters |
| Semaglutide 4 months, cycles still irregular, weight loss under 5% | Switch to tirzepatide | Non-response is the clearest reason to change |
Metformin is not the competitor
Metformin remains first-line for PCOS insulin resistance in Indian guidelines and it is cheap. GLP-1s are added when metformin and lifestyle change have not moved weight or cycles, or when BMI is high. Many of our PCOS patients stay on metformin alongside a GLP-1. See metformin vs semaglutide.
PCOS and stuck?
Take the free 2-minute assessment. Dr. Archana Rathi, diabetologist, and Dr. Mujeeb Afzal, endocrinologist, see PCOS patients directly and will tell you which molecule, if any, fits your reports and your plans.
Key takeaways
- Both drugs help PCOS because both lower insulin; tirzepatide lowers it more, semaglutide has more PCOS-specific evidence and costs a fifth as much.
- Tirzepatide reduces oral contraceptive absorption around dose changes; semaglutide does not.
- Semaglutide first for most women with BMI under 32; tirzepatide for high BMI with marked insulin resistance, if affordable.
- Both are stopped two months before trying to conceive.
Frequently asked questions
Which is better for PCOS, semaglutide or tirzepatide?
Tirzepatide has a stronger effect on insulin resistance and weight; semaglutide has more PCOS-specific trial data, no contraceptive interaction, and costs about a fifth as much since generics. For most women with BMI under 32, semaglutide is the sensible start.
Does Mounjaro affect the contraceptive pill?
Yes. Tirzepatide reduces absorption of oral contraceptives for about four weeks after starting and after each dose increase. Use a barrier or non-oral method in those windows. Semaglutide has no such warning.
Can GLP-1s restore periods in PCOS?
In most studies, a majority of women with PCOS who lose 5% or more of body weight on semaglutide regain regular cycles. Tirzepatide is expected to do the same or better; its PCOS-specific data is still emerging.
Can I take semaglutide or tirzepatide while trying to get pregnant?
No. Both are stopped at least two months before trying to conceive and are not used in pregnancy.
It was never about willpower.
PCOS runs on insulin resistance. Our physician looks at the whole picture and tells you honestly what will help. Two minutes, and a doctor reviews every one.
This article is for general educational purposes and is not a substitute for personalised medical advice. GLP-1 medications are prescription-only and not suitable for everyone. Always consult a qualified doctor before starting, changing, or stopping any treatment.
